Tenaya Therapeutics to Present at Morgan Stanley 19th Annual Global Healthcare Conference
August 31 2021 - 8:00AM
Business Wire
Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a biotechnology
company with a mission to discover, develop and deliver curative
therapies that address the underlying causes of heart disease,
announced today that Faraz Ali, Chief Executive Officer, will
participate in a virtual fireside chat at the Morgan Stanley 19th
Annual Global Healthcare Conference on Friday, September 10th at
2:45 p.m. Eastern Time/11:45 a.m. Pacific Time.
About Tenaya Therapeutics
Tenaya Therapeutics is a biotechnology company committed to a
bold mission: to discover, develop and deliver curative therapies
that address the underlying drivers of heart disease. Founded by
leading cardiovascular scientists from Gladstone Institutes and the
University of Texas Southwestern Medical Center, Tenaya is
developing therapies for rare genetic disorders as well as for more
prevalent heart conditions through three distinct but interrelated
product platforms: Gene Therapy, Cellular Regeneration and
Precision Medicine.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210831005296/en/
Investor Relations: Leone Patterson Tenaya Therapeutics
IR@tenayathera.com
Media: Wendy Ryan Ten Bridge Communications
wendy@tenbridgecommunications.com (781) 316-4424
Tenaya Therapeutics (NASDAQ:TNYA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Tenaya Therapeutics (NASDAQ:TNYA)
Historical Stock Chart
From Apr 2023 to Apr 2024